SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 64 filers reported holding SYNTHETIC BIOLOGICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $356,000 | -53.6% | 466,839 | 0.0% | 0.00% | – |
Q3 2016 | $767,000 | -8.7% | 466,839 | 0.0% | 0.00% | – |
Q2 2016 | $840,000 | -23.8% | 466,839 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $1,102,000 | +3.1% | 466,839 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $1,069,000 | -4.2% | 466,839 | -5.1% | 0.00% | 0.0% |
Q3 2015 | $1,116,000 | – | 491,839 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 2,034,949 | $1,553,000 | 2.72% |
Third Security, LLC | 13,238,268 | $10,095,000 | 0.54% |
MSD Partners, L.P. | 4,118,402 | $3,141,000 | 0.16% |
SABBY MANAGEMENT, LLC | 3,031,953 | $2,312,000 | 0.13% |
Alyeska Investment Group, L.P. | 10,000,000 | $7,626,000 | 0.06% |
BARD ASSOCIATES INC | 87,999 | $67,000 | 0.03% |
Alyeska Investment Group, L.P. | 4,586,592 | $3,498,000 | 0.03% |
FRANKLIN STREET ADVISORS INC /NC | 126,000 | $96,000 | 0.02% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,000,000 | $763,000,000 | 0.02% |
HAMILTON LANE ADVISORS LLC | 23,855 | $18,000 | 0.01% |